EntryPoint Capital’s Sotera Health SHC Stock Holding History

EntryPoint Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,819	Closed	-$686K	–	947
2026 Q1	$686K	Buy	47,819 +37,588	+367%	+$624K	0.2%	147
2025 Q4	$180K	Hold	10,231	–	–	0.07%	569
2025 Q3	$161K	Buy	+10,231	New	+$144K	0.06%	579
2024 Q2	–	Sell	-19,181	Closed	-$230K	–	1812
2024 Q1	$230K	Buy	+19,181	New	+$285K	0.21%	73

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

EntryPoint Capital's SHC Position: Q2 2026 in Review

EntryPoint Capital sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 47,819 shares — an estimated $686K sold.

EntryPoint Capital first reported a position in SHC in Q1 2024 and held it in 4 quarters. The position peaked at $686K in Q1 2026. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

EntryPoint Capital reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
EntryPoint Capital sold 47,819 Sotera Health shares in Q2 2026, an estimated $686K.
EntryPoint Capital first reported a position in Sotera Health in Q1 2024 and held it in 4 quarters.
EntryPoint Capital's Sotera Health position peaked at $686K in Q1 2026.
320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.